ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 125845 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 125845; 2) Community: the network communities that were significantly associated with the response to NSC 125845; 3) Molecule: the relationships between components within communities and NSC 125845; 4) MDR: the compounds that were significantly associated with the NSC 125845.

NSC Compound Enrichment Correlation
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0013655184802855 0.33334317
NSC 744688 Null 0.0013655184802855 0.48616751
NSC 268242 N,N-Dibenzyldaunorubicin 0.00140570135773563 0.55818148
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00140570135773563 0.49293257
NSC 376739 5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00140570135773563 0.46520246
NSC 654509 Pirarubicin HCl 0.00140570135773563 0.44171321
NSC 689531 Hydrazinecarbothioamide, 2-[(2-pyridinyl)phenylmethylene]-N-[2-(2-pyridinyl)ethyl]- 0.00140570135773563 0.296889
NSC 716951 Null 0.00140570135773563 0.57282561
NSC 720447 Null 0.00140570135773563 -0.21402787
NSC 740 Methotrexate 0.00140570135773563 0.66264182
Total:103  Current:10    [First] [Prev] [Next] [Last]